MAPT and Alzheimer disease: AD’s pathophysiological mechanisms have not been fully elucidated, though they mostly encompass amyloid-beta peptide accumulation in brain tissues and changes in the phosphorylation of Tau proteins in neurons which cause cytoskeletal impairments [16].